CARECLOUD(US:CCLDO)2024-08-13 20:30Financial Performance - For the three months ended June 30, 2024, net revenue was $28,090,000, a decrease of 4.3% from $29,362,000 in the same period of 2023[153]. - Adjusted EBITDA for the six months ended June 30, 2024, was $10,076,000, an increase of 24.9% compared to $8,056,000 for the same period in 2023[153]. - The company reported a GAAP net income of $1,674,000 for the three months ended June 30, 2024, compared to a loss of $1,832,000 in the same period of 2023[153]. - Non-GAAP adjusted net income for Q2 2024 was $2.958 million, up from $1.410 million in Q2 2023, indicating a year-over-year increase of 109%[156]. - Total revenue for Q2 2024 was $28.1 million, a decrease of 4% from $29.4 million in Q2 2023[173]. - The company reported an income before income taxes of $1.7 million for the three months ended June 30, 2024, compared to a loss of $1.8 million for the same period in 2023[196]. Operational Efficiency - Adjusted operating income for the three months ended June 30, 2024, was $3,249,000, up from $1,724,000 in the same period of 2023, reflecting a significant improvement in operational efficiency[153]. - The adjusted operating margin for the three months ended June 30, 2024, was 11.6%, compared to 5.9% in the same period of 2023, indicating enhanced profitability[153]. - Direct operating costs as a percentage of net revenue decreased to 54.3% in Q2 2024 from 59.5% in Q2 2023, reflecting improved operational efficiency[173]. - Selling and marketing expenses as a percentage of net revenue decreased to 5.9% in Q2 2024 from 8.8% in Q2 2023[173]. - General and administrative expenses as a percentage of net revenue decreased to 14.3% in Q2 2024 from 20.1% in Q2 2023[173]. - Direct operating costs decreased by $2.2 million (13%) and $5.2 million (15%) for the three and six months ended June 30, 2024, compared to the same periods in 2023[175]. Revenue Sources - Revenue from technology-enabled business solutions accounted for approximately 68% of total revenue in Q2 2024, compared to 67% in Q2 2023[160]. - Medical practice management services generated approximately 12% of total revenue in both Q2 2024 and Q2 2023[161]. - Project-based professional services revenue decreased by $1.0 million (13%) and $3.2 million (15%) for the three and six months ended June 30, 2024, compared to the same periods in the prior year[174]. - Revenue from two large accounts contributed to a decline of approximately $1.7 million in revenue for the six months ended June 30, 2024, with revenue from these customers dropping from $2.0 million to $299,000[174]. Cost Management - Personnel-related costs accounted for approximately 76% of total expenses in offshore operations for the six months ended June 30, 2024, providing a competitive advantage due to lower costs[148]. - Selling and marketing expenses decreased by $916,000 (36%) and $1.8 million (34%) for the three and six months ended June 30, 2024, respectively[176]. - General and administrative expenses decreased by $1.9 million (32%) and $3.3 million (30%) for the three and six months ended June 30, 2024, respectively[177]. - Research and development expenses decreased by approximately $130,000 (11%) and $295,000 (13%) for the three and six months ended June 30, 2024, respectively[178]. - Amortization expenses increased by $381,000 (13%) and $1.3 million (23%) for the three and six months ended June 30, 2024, respectively[180]. Cash and Capital Management - As of June 30, 2024, the company had total cash of $2.6 million and net working capital of $674,000[187]. - The company expects approximately $22.0 million in annualized cost savings, with $16.0 million realized during 2024[189]. - Net cash provided by operating activities was $8.3 million, an increase of 13% compared to $7.4 million for the same period in 2023[196]. - Net cash used in investing activities decreased to $3.5 million for the six months ended June 30, 2024, from $6.1 million in 2023, representing a 43% reduction[198]. - Capital expenditures for the six months ended June 30, 2024, were $425,000, down from $1.6 million in 2023[198]. - Software development costs capitalized were $3.0 million for the six months ended June 30, 2024, compared to $4.5 million in 2023[198]. Compliance and Security - The company has not identified any compromise or unauthorized access of its systems due to the Change Healthcare Cybersecurity Incident as of June 30, 2024[193]. - The company has maintained compliance with all covenants under its line of credit as of June 30, 2024[200].